FIELD: medicine.
SUBSTANCE: substance of invention includes separated population of hematopoetic stem cells of negative lineage, (Lin- HSC), containing progenitor endotheliocytes (EPC), protecting retina blood vessels and neuronal eye networks, method of separation of hematopoetic stem cell population of negative lineage from bone marrow of mammal adult, herewith approximately 20% of cells in separated Lin- HSC express cell surface CD31.
EFFECT: possibility to apply for treatment of eye vascular diseases.
22 cl, 10 ex, 24 dwg
Authors
Dates
2009-02-10—Published
2004-04-28—Filed